The Development of Vδ1 Gamma Delta T cell Platforms For Use In Next-Generation Allogeneic CAR Therapies
Time: 3:30 pm
day: Conference Day Two
Details:
- Harnessing the potential of γδ T cells for immunotherapy in solid and hematological malignancies
- Investigating the advancements of allogeneic Vδ1 γδ T cell therapy platforms
- Preclinical update on the progress of cell therapy programs utilizing Vδ1 γδ T cells